Akari Therapeutics Reports Full Year 2020 Financial Results and Highlights Recent Clinical Progress
Go back to Akari Therapeutics Reports Full Year 2020 Financial Results and Highlights Recent Clinical Progress(NASDAQ: AKTX) | Delayed: 1.21 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $1.21 | 52 Week High | $19.75 | |||
Open | $1.21 | 52 Week Low | $7.63 | |||
Day High | $1.21 | P/E | N/A | |||
Day Low | $1.21 | EPS | $0.00 | |||
Volume | 88 |